NCT06755970

Brief Summary

This study will use a randomized controlled experimental research design. The population of the study will consist of all adult patients who undergo laparoscopic cholecystectomy at the General Surgery Clinic of Atatürk University Research Hospital between December 2024 and September 2025. The data will be collected using a Descriptive Information Form and the Visual Analogue Scale. The research has received institutional approval and ethics committee approval. The study will be conducted with collaboration from healthcare professionals in the clinic after they have been informed. Patients who meet the inclusion criteria will be invited to participate in the study after being approached one day before surgery. Oral and written consent will be obtained from those who volunteer and agree to participate. The data will be analyzed using SPSS for Windows 22 software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

December 18, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 21, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

December 18, 2024

Last Update Submit

July 20, 2026

Conditions

Keywords

PainLaparoscopic cholecystectomyNausea

Outcome Measures

Primary Outcomes (5)

  • Visual Analog Scale (VAS)

    Patients are asked to rate their pain level on a horizontal line between 0 and 10. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, it is used as the most suitable tool to assess pain intensity. It can be used to evaluate both pain and nausea.

    2nd hour after surgery

  • Visual Analog Scale (VAS)

    Patients are asked to rate their pain level on a horizontal line between 0 and 10. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, it is used as the most suitable tool to assess pain intensity. It can be used to evaluate both pain and nausea.

    4nd hour after surgery

  • Visual Analog Scale (VAS)

    Patients are asked to rate their pain level on a horizontal line between 0 and 10. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, it is used as the most suitable tool to assess pain intensity. It can be used to evaluate both pain and nausea.

    8nd hour after surgery

  • Visual Analog Scale (VAS)

    Patients are asked to rate their pain level on a horizontal line between 0 and 10. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, it is used as the most suitable tool to assess pain intensity. It can be used to evaluate both pain and nausea.

    12nd hour after surgery

  • Visual Analog Scale (VAS)

    Patients are asked to rate their pain level on a horizontal line between 0 and 10. 0 represents no pain, and 10 represents unbearable pain. Due to its simplicity, validity, and reliability, it is used as the most suitable tool to assess pain intensity. It can be used to evaluate both pain and nausea.

    24nd hour after surgery

Study Arms (2)

Experimental: Grup 1

EXPERIMENTAL

The ICOUGH care bundle will be applied to this group.

Procedure: ICOUGH

Control grup: Grup 2

NO INTERVENTION

The ICOUGH care bundle will not be applied to this group.

Interventions

ICOUGHPROCEDURE

After the patient has recovered from postoperative anesthesia and their hemodynamic values have stabilized, the ICOUGH bundle applications mentioned above will be carried out. The patient's pain and nausea levels will be recorded for a period of 24 hours. Postoperative pain and nausea will be assessed with the help of data collectors, using a numerical rating scale at 2, 4, 8, 12 and 24 hours after surgery. Considering that postoperative respiratory complications are relatively common and costly, various studies have been conducted to explore ways to reduce the risk of their occurrence. One of these protocols is the ICOUGH bundle, which stands for Incentive Spirometry, Coughing and Deep Breathing, Oral Care, Patient Understanding of the Interventions, Getting Out of Bed, and Head of Bed Elevation.

Experimental: Grup 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who agree to participate in the study and volunteer
  • Aged 18 and above
  • Undergoing laparoscopic cholecystectomy surgery under general anesthesia
  • Those without physical or mental disabilities, limitations, or conditions that would prevent them from performing respiratory exercises (such as the use of medications affecting respiration, conditions requiring oxygen therapy, etc.)
  • Those whose cognitive level is suitable for the application of scales
  • Patients without communication problems will be included in the study

You may not qualify if:

  • Those whose hemodynamic values are not stable after the surgical intervention
  • Those who develop any complications such as severe bleeding, nausea, vomiting, etc., after surgery
  • Patients with acute or chronic lung diseases
  • Patients who voluntarily wish to withdraw from the study will not be included in the study
  • Required postoperative mechanical ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University

Erzurum, 25300, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainNausea

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pricipal investigator

Study Record Dates

First Submitted

December 18, 2024

First Posted

January 1, 2025

Study Start

December 1, 2024

Primary Completion

June 1, 2025

Study Completion

October 1, 2025

Last Updated

July 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations